ViiV Healthcare Says U.S FDA Approved Triumeq PD For Children Living With Hiv

 VIIV-US FDA APPROVAL OF TRIUMEQ PD,FIRST DISPERSIBLE SINGLE TABLET REGIMEN CONTAINING DOLUTEGRAVIR, ONCE-DAILY TREATMENT FOR CHILDREN LIVING WITH HIV

* VIIV-IN ADDITION, SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) HAS BEEN APPROVED FOR TRIUMEQ TABLET

https://www.marketscreener.com/quote/stock/GLAXOSMITHKLINE-PLC-9590199/news/ViiV-Healthcare-Says-U-S-FDA-Approved-Triumeq-PD-For-Children-Living-With-Hiv-39915807/